Arcturus Therapeutics Holdings Inc. - ARCT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Balyasny Asset Management L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BAM GP LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Balyasny Asset Management Holdings LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dames GP LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dmitry Balyasny | 0.0% | 0 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | ARK Investment Management LLC | 9.19% | 2,611,099 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Catherine D. Wood | 9.19% | 2,611,099 | View |
| Nov 14, 2025 | SCHEDULE 13G | Balyasny Asset Management L.P. | 8.04% | 2,183,985 | View |
| Nov 14, 2025 | SCHEDULE 13G | BAM GP LLC | 8.04% | 2,183,985 | View |
| Nov 14, 2025 | SCHEDULE 13G | Balyasny Asset Management Holdings LP | 8.04% | 2,183,985 | View |
| Nov 14, 2025 | SCHEDULE 13G | Dames GP LLC | 8.04% | 2,183,985 | View |
| Nov 14, 2025 | SCHEDULE 13G | Dmitry Balyasny | 8.04% | 2,183,985 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Amova Asset Management Americas, Inc. | 7.2% | 1,947,835 | View |
| Oct 27, 2025 | SCHEDULE 13G/A | Sumitomo Mitsui Trust Group, Inc. | 7.2% | 1,947,835 | View |
| Oct 27, 2025 | SCHEDULE 13G/A | Amova Asset Management Co., Ltd. | 7.2% | 1,947,835 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.